2 Agriculture - Products Stocks to Buy in a Promising Industry

Agriculture–Products is framed as benefiting from stable food demand from population growth (UN: 8.5B by 2030, 9.7B by 2050) and faster growth from controlled-environment agriculture (hydroponics/vertical farming). Industry valuation screens as cheaper at 10.17x TTM EV/EBITDA vs 18.51x for the S&P 500, alongside positive near-term prospects from a Zacks Industry Rank of #99 (top 41%). Stock-specific catalysts include Bunge’s July 2025 $34B Viterra merger and early integration benefits, while GrowGeneration reports Q3 2025 net sales +15.4% sequentially, returning to positive adjusted EBITDA of $1.3M and gross margin >27%.

Analysis

BG has the cleaner rerating path because the Viterra combination is not just scale, it is optionality across origination, freight, and storage that can lower earnings volatility and improve ROIC even if commodity prices go nowhere. The second-order loser is less the farmer and more the mid-tier merchandiser: larger platforms can internalize more basis spread and working-capital efficiency, which tends to squeeze weaker regional operators and keeps ADM-style peers from passing through as much margin on the commercial side.

GRWG is more of a cost-out recovery than a true secular compounder. The equity can work if controlled-environment cultivation capex and cannabis-related retail spend recover, but the business still looks fragile to any pause in store traffic or pricing pressure from private label and online distributors, so gross-margin gains may not scale cleanly. The market is likely to overestimate how much a few quarters of expense discipline can offset a structurally uneven demand base.

The key catalyst window is 1-3 months for BG around integration commentary, synergy capture, and capital-return credibility; for GRWG the real test is 2-4 quarters, not one quarter, because the falsifier is a relapse in revenue growth once cost cuts have been harvested. Contrarian view: the consensus is treating agricultural demand as defensive, but the better signal is execution quality; if freight, spreads, or capex stay soft, the current multiple can compress back toward the lower half of its five-year range rather than re-rate higher.

Key Decisions for Investors

• Long BG / short ADM over 3-6 months: BG has the clearer synergy and capital-allocation upside, while ADM is more exposed to margin normalization and less to footprint re-optimization. Add on weakness after earnings; cut if BG trims synergy targets or relative strength breaks.
• Buy BG only on a pullback of 5%+ from current levels and target a 10-15% move over 6 months if integration metrics stay on track. Falsifier: any sign that working-capital intensity rises instead of falls.
• Do not chase GRWG outright yet; wait for at least two consecutive quarters of positive adjusted EBITDA and top-line stabilization before considering a small long. Until then, treat it as a watch item rather than a conviction buy.
• If GRWG does confirm demand recovery, use a call spread rather than stock to cap downside from another capex air pocket; risk/reward only becomes attractive if revenue acceleration is visible, not just cost cuts.
• Watch ADM and other grain merchandisers for read-through pressure on commercial spreads; if BG’s integration is working, peers should see slower margin recovery, making a relative-value short basket more attractive on any sector rally.